Does Size Matter? These Two Small-Cap Cannabis Stocks Are Masters Of Cash Flow And Credit Management
Does Size Matter? These Two Small-Cap Cannabis Stocks Are Masters Of Cash Flow And Credit Management
大小是否重要？這兩隻小市值大麻股票是現金流和信貸管理方面的專家。
C21 Investments (OTC:CXXI) and Vext Science (OTC:VEXT) have demonstrated notable financial performance, particularly in cash flow and credit stability. This is significant given the challenges faced by many larger cannabis companies.
C21投資（場外交易：CXXI）和Vext Science（場外交易：VEXT）表現突出，尤其是在現金流和信用穩定方面。這一點在許多更大的大麻股公司面臨挑戰的情況下顯得尤爲重要。
Despite market caps of $29.98 million for Vext and $33.33 million for C21, they outperform larger peers like Tilray (NASDAQ:TLRY) with a market cap of $1.53 billion, Curaleaf (OTC:CURLF) with a market cap of $3.10 billion, and Trulieve (OTC:TCNNF) with a market cap of $1.69 billion.
儘管Vext的市值爲2998萬美元，而C21的市值爲3333萬美元，但它們的表現優於市值爲15.3億美元的Tilray（納斯達克：TLRY）、市值爲31億美元的Curaleaf（場外交易：CURLF）和市值爲16.9億美元的Trulieve（場外交易：TCNNF）等較大的同行。
Comparative Analysis With Major Cannabis Stocks
與主要大麻股票的比較分析
The leveraged free Cash Flow Margin (LFCFM) indicates how efficiently a company converts its revenue into cash after covering...
槓桿自由現金流利潤率（LFCFM）表示...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。